R01 CA130202/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	2
2009	1
2010	1
2012	1
2013	1
2014	1
2015	3
2016	1
2017	1
2019	1
2021	1
2022	1
2024	0

1

Melanocytes, melanocyte stem cells, and melanoma stem cells.

Lang D, Mascarenhas JB, Shea CR. Lang D, et al. Clin Dermatol. 2013 Mar-Apr;31(2):166-78. doi: 10.1016/j.clindermatol.2012.08.014. Clin Dermatol. 2013. PMID: 23438380 Free PMC article. Review.

2

FOXD3 Promotes PAX3 Expression in Melanoma Cells.

Kubic JD, Little EC, Kaiser RS, Young KP, Lang D. Kubic JD, et al. J Cell Biochem. 2016 Feb;117(2):533-41. doi: 10.1002/jcb.25306. Epub 2015 Sep 1. J Cell Biochem. 2016. PMID: 26252164 Free PMC article.

3

Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease.

Kubic JD, Young KP, Plummer RS, Ludvik AE, Lang D. Kubic JD, et al. Pigment Cell Melanoma Res. 2008 Dec;21(6):627-45. doi: 10.1111/j.1755-148X.2008.00514.x. Pigment Cell Melanoma Res. 2008. PMID: 18983540 Free PMC article. Review.

4

Canonical and alternative transcript expression of PAX6 and CXCR4 in pancreatic cancer.

Little EC, Kubic JD, Salgia R, Grippo PJ, Lang D. Little EC, et al. Oncol Lett. 2017 Jun;13(6):4027-4034. doi: 10.3892/ol.2017.5956. Epub 2017 Mar 29. Oncol Lett. 2017. PMID: 28588695 Free PMC article.

5

YAP facilitates melanoma migration through regulation of actin-related protein 2/3 complex subunit 5 (ARPC5).

Lui JW, Moore SPG, Huang L, Ogomori K, Li Y, Lang D. Lui JW, et al. Pigment Cell Melanoma Res. 2022 Jan;35(1):52-65. doi: 10.1111/pcmr.13013. Epub 2021 Sep 1. Pigment Cell Melanoma Res. 2022. PMID: 34468072 Free PMC article.

6

PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma.

Kubic JD, Lui JW, Little EC, Ludvik AE, Konda S, Salgia R, Aplin AE, Lang D. Kubic JD, et al. J Biol Chem. 2015 Sep 4;290(36):21901-14. doi: 10.1074/jbc.M115.670976. Epub 2015 Jul 23. J Biol Chem. 2015. PMID: 26205821 Free PMC article.

7

GSK-3 promotes cell survival, growth, and PAX3 levels in human melanoma cells.

Kubic JD, Mascarenhas JB, Iizuka T, Wolfgeher D, Lang D. Kubic JD, et al. Mol Cancer Res. 2012 Aug;10(8):1065-76. doi: 10.1158/1541-7786.MCR-11-0387. Epub 2012 Jun 7. Mol Cancer Res. 2012. PMID: 22679108 Free PMC article.

8

The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma.

Lui JW, Xiao S, Ogomori K, Hammarstedt JE, Little EC, Lang D. Lui JW, et al. J Cancer. 2019 Jan 1;10(1):1-10. doi: 10.7150/jca.27472. eCollection 2019. J Cancer. 2019. PMID: 30662519 Free PMC article.

9

PAX3 and ETS1 synergistically activate MET expression in melanoma cells.

Kubic JD, Little EC, Lui JW, Iizuka T, Lang D. Kubic JD, et al. Oncogene. 2015 Sep 17;34(38):4964-74. doi: 10.1038/onc.2014.420. Epub 2014 Dec 22. Oncogene. 2015. PMID: 25531327 Free PMC article.

10

PAX3 expression in primary melanomas and nevi.

Plummer RS, Shea CR, Nelson M, Powell SK, Freeman DM, Dan CP, Lang D. Plummer RS, et al. Mod Pathol. 2008 May;21(5):525-30. doi: 10.1038/modpathol.3801019. Epub 2008 Mar 7. Mod Pathol. 2008. PMID: 18327212 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year